 products. Changes of antibody titers will be measured by flow cytometry and by panel lymphocytotoxic antibody reactivity. Retrospective crossmatches will be performed to determine if 10W level anti-donor antibodies consistently induce poor transfusion responses or acceptable increments can still occur in their presence. The results of the proposed studies will not only allow
products. Changes of antibody titers will be measured by menstruation cytometry and by dialog box lymphocytotoxic antibody reactivity. Retrospective crossmatches will be performed to determine if 10W charge anti - donor antibodies consistently induce inadequate transfusion reception or acceptable increase can still occur in their bearing. The results of the proposed studies will not only admit
 prlducts. Changes of antiboay titers will yw measnred by flow cygometry and by panel lymphocbtotixic qntibody reactivity. Regrospectine crossmqtchts will be performed to dccermihc if 10C oevel anti-donot antibodies consistently hnauee poor transfusion responses or accqptable ijcrements can ftilk occhg ln their presence. The results of the prmposed studiex will not only allow
products. Changes of antibody titers will be flow and by lymphocytotoxic antibody reactivity. to if 10W level antibodies consistently induce transfusion responses or acceptable increments can occur in their presence. The results of the proposed studies will not only
 products. Changes of antibody Titers will Be meaSurEd bY fLow cYtomEtry and by panel LYmphOcytotoxic antibody reacTivitY. RETrosPEcTive cRossmatCHeS WIll Be PeRfoRmED tO deteRmiNe if 10W leVel anti-donOr aNtIbodies consiSTeNtly induce PooR transfusion ResPonses Or AccEPtablE inCremeNts can STill ocCur in theiR pREsence. tHe resulTS Of The pRoposed studies wilL NoT Only allow
 products. Changes of anti body titer s wil l b e m ea sure d by  flow cytometr y  and  by panel lymphocytoto xic a nt i body re activ ity. Re t ro s p ect iv ecro ss m at cheswil l be pe rformed to  de te rmine if 10W le vel anti-d ono r antibodies  co nsiste nt lyi nduce  po or tr ansfus i on res ponses or  a c ceptab l e incre m e nt s ca n still occur int he i r presence. Th e resu lt s  o f the  pr oposed stu di es wi l l not o n ly a l low 
 products._Changes of_antibody titers will be_measured by_flow_cytometry and_by_panel lymphocytotoxic antibody_reactivity. Retrospective crossmatches_will be performed to_determine if 10W_level_anti-donor antibodies consistently induce poor transfusion responses or acceptable increments can still occur in_their_presence. The_results_of_the proposed studies will not_only allow